1. Home
  2. KALV vs CRSR Comparison

KALV vs CRSR Comparison

Compare KALV & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$15.75

Market Cap

757.7M

Sector

Health Care

ML Signal

HOLD

Logo Corsair Gaming Inc.

CRSR

Corsair Gaming Inc.

HOLD

Current Price

$5.37

Market Cap

616.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
CRSR
Founded
N/A
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Manufacturing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
757.7M
616.0M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
KALV
CRSR
Price
$15.75
$5.37
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$30.00
$8.50
AVG Volume (30 Days)
721.4K
1.8M
Earning Date
03-25-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.37
EPS
N/A
N/A
Revenue
$50,000,000.00
$1,472,480,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.90
P/E Ratio
N/A
N/A
Revenue Growth
495.66
11.86
52 Week Low
$9.83
$4.48
52 Week High
$19.00
$10.41

Technical Indicators

Market Signals
Indicator
KALV
CRSR
Relative Strength Index (RSI) 45.58 45.90
Support Level $14.59 $4.48
Resistance Level $16.49 $6.19
Average True Range (ATR) 0.98 0.31
MACD -0.06 -0.05
Stochastic Oscillator 13.35 15.45

Price Performance

Historical Comparison
KALV
CRSR

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.

Share on Social Networks: